Enzon Pharmaceuticals's total assets for Q were $47.28M, an increase of 0.60% from the previous quarter. ENZN total liabilities were $438.00K for the fiscal quarter, a 6.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.